Effect of heparin and plasminogen inhibitor (EACA) on intravenously injected ascites tumour cells.
D000614:Aminocaproates / Q000494:pharmacology*; D000818:Animals; D006493:Heparin / Q000494:pharmacology*; D007275:Injections, Intravenous; D008175:Lung Neoplasms / Q000473:pathology; D051379:Mice; D009362:Neoplasm Metastasis; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000473:pathology*; D009360:Neoplastic Cells, Circulating; D010529:Peritoneal Cavity / Q000473:pathology; D012208:Rhabdomyosarcoma / Q000473:pathology
D000614:Aminocaproates; D006493:Heparin